Using existing drugs to fight tumours is a prospective emerging from an increasing number of international studies. The latest confirmation of this trend comes from a study conducted at IFOM and IEO in Milan that combines knowledge obtained in the fields of genetic research and pharmacology, opening the way to possible new uses for drugs already on the market. The study, realized in collaboration with the University of Milan, will be published online today in the prestigious journal Nature.